Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.92 USD
Change Today -0.50 / -11.31%
Volume 1.6M
SZYM On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for solazyme inc (SZYM)

Solazyme, Inc. may have more financial risk than other companies in the Oil, Gas and Consumable Fuels industry as it is one of the most highly leveraged with a Debt to Total Capital ratio of 69.85%. This ratio actually increased over the last year. However, an examination of near-term assets and liabilities shows that there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 57.88 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 44.91 days.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents28.830.855.042.7
Short-Term Investments214.9118.2112.5164.6
TOTAL CASH AND SHORT TERM INVESTMENTS243.7149.0167.5207.3
Accounts Receivable7.96.411.67.6
TOTAL RECEIVABLES7.96.411.67.6
Inventory3.16.99.815.3
Prepaid Expenses4.13.02.93.7
TOTAL CURRENT ASSETS258.9165.3191.8233.9
Gross Property Plant and Equipment28.838.551.453.0
Accumulated Depreciation-2.8-6.3-11.3-16.9
NET PROPERTY PLANT AND EQUIPMENT26.032.240.136.1
Long-Term Investments--19.022.540.9
Other Long-Term Assets0.30.54.31.6
TOTAL ASSETS285.2217.0258.7312.6
    
LIABILITIES & EQUITY    
Accounts Payable11.57.67.98.3
Accrued Expenses9.39.312.412.3
Current Portion of Long-Term Debt/Capital Lease5.37.30.10.0
Other Current Liabilities, Total0.10.42.61.8
Unearned Revenue, Current3.00.32.31.1
TOTAL CURRENT LIABILITIES29.224.925.323.5
Long-Term Debt15.07.693.5200.1
Unearned Revenue, Non-Current------0.2
Other Non-Current Liabilities0.51.11.02.5
TOTAL LIABILITIES44.733.7119.8226.2
Common Stock0.10.10.10.1
Additional Paid in Capital348.1373.6449.0565.8
Retained Earnings-106.8-189.9-306.3-468.5
Comprehensive Income and Other-0.8-0.4-3.8-11.0
TOTAL COMMON EQUITY240.6183.3138.986.4
TOTAL EQUITY240.6183.3138.986.4
TOTAL LIABILITIES AND EQUITY285.2217.0258.7312.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SZYM:US $3.92 USD -0.50

SZYM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SZYM.
View Industry Companies
 

Industry Analysis

SZYM

Industry Average

Valuation SZYM Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLAZYME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.